-
Mounjaro: New weight loss drug approved for use in Britain to be available ‘within weeks’ | UK News
admin
An American weight loss drug approved in a four-dose injection pen format for use in Britain could be available “within weeks”. Mounjaro, also known as tirzepatide, is a diabetes drug that was authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) to help obese and overweight adults lose and manage weight in November last…
-
Blinatumomab: The new cancer drug helping unwell children that is kinder and more targeted than chemotherapy | UK News
admin
An 11-year-old boy, who is now free of blood cancer after undergoing a new type of treatment, has told Sky News the drug gave him a “burst of energy”. Arthur D’Hulst had leukaemia but traditional chemotherapy failed to clear it, leaving him very weak, and the side effects were rough. He was offered a new…
-
World-first trial finds arthritis drug may help treat type 1 diabetes | Science & Tech News
admin
A world-first clinical trial has found a common drug used to treat rheumatoid arthritis can suppress the progression of type 1 diabetes in recently diagnosed patients. Researchers at St Vincent’s Institute of Medical Research in Melbourne, Australia, discovered baricitinib can preserve the body’s own insulin production. They described the finding as “a huge step-change” in…
-
‘Repurposed’ drug that could prevent breast cancer to be offered to nearly 300,000 women | UK News
admin
A “repurposed” drug that could prevent breast cancer as well as treat it will be offered to almost 300,000 women, NHS officials have revealed. Anastrozole has been used to treat hormone-sensitive breast cancer. But trials have shown it can also stop the disease from occurring in the first place. It’s predicted cases could be cut…
-
Molnupiravir: COVID drug linked to virus mutations, scientists say | Science & Tech News
admin
A drug used to treat COVID-19 could be linked to mutations in the virus, scientists have said. Molnupiravir works by causing mutations in the virus’s genetic information, or genome, many of which kill or harm the virus, reducing the amount of COVID in the body. Used across the world to treat COVID, it was one…
-
Alzheimer’s: First drug to slow progression of disease gains approval of US regulator the FDA | Science & Tech News
admin
The US Food and Drug Administration (FDA) has fully approved a drug that slows the progression of Alzheimer’s disease for the first time. The FDA has granted full regulatory approval to Leqembi – a drug by Japanese manufacturers Eisai and US drugmakers Biogen. Up to now, other approved drugs targeted only the symptoms of the…
-
New drug can reduce Alzheimer’s disease symptoms by up to 35% | Science & Tech News
admin
A second drug has shown the ability to slow the progression of the leading form of dementia. Results of a study, released in a preliminary form by drug maker Eli Lilly, show their drug donanemab reduced the rate of cognitive decline of Alzheimer’s patients in a trial by between 27 and 35%. Those on the…
-
New long COVID drug may significantly reduce fatigue in patients | UK News
admin
An experimental drug could significantly reduce fatigue in people with long COVID, a new study suggests. Scientists who carried out the small-scale clinical trial believe the drug, called AXA1125, may increase energy production in cells and reduce inflammation for people fighting the virus and its aftereffects. They are calling for larger studies to confirm the…
-
‘Encouraging’ results in trial of psychedelic drug for treating depression | UK News
admin
A psychedelic drug which causes half-an-hour trips has shown some success in treating depression, early trial results suggest. Early evidence from a small trial suggests the powerful pharmaceutical-grade hallucinogenic – known as intravenous DMT, or SPL026 – could improve symptoms of moderate to severe depression when used in conjunction with therapy. According to un-peer reviewed…
-
What is Alzheimer’s disease, how common is it – and will new drug lecanemab help patients in the UK? | UK News
admin
A new drug is making headlines around the world for being the first ever to slow the progression of Alzheimer’s disease. After an 18-month trial of 1,800 patients, lecanemab slowed patients’ mental decline by 27%. Although scientists are hailing a “new era” in treatment, strains on the NHS and the scale and complexity of the…